12/09/2024
11:15 PM | Eagle Pharmaceuticals (Filer)
| Form EFFECT | |
12/02/2024
3:17 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:05 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:06 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:06 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:07 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:07 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
|
11/27/2024
3:07 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:08 PM | Eagle Pharmaceuticals (Filer)
| Form POS AM | |
11/27/2024
3:08 PM | Eagle Pharmaceuticals (Filer)
| Form RW | |
11/27/2024
8:25 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
6:59 PM | Eagle Pharmaceuticals (Issuer)
Krawtschuk Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/15/2024
4:19 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
10:34 AM | BRANDES INVESTMENT PARTNERS, LP (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
9:25 AM | Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/13/2024
7:30 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/12/2024
6:08 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:32 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G/A | |
10/31/2024
12:36 PM | Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
| Form SC 13G/A | |
10/31/2024
7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:05 PM | Eagle Pharmaceuticals (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
10/08/2024
11:42 AM | Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
| Form SC 13G | |
10/02/2024
8:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:30 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
3:35 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/05/2024
8:03 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G/A | |
07/03/2024
1:02 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G | |
05/29/2024
7:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
8:08 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:29 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
4:27 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
7:37 PM | Eagle Pharmaceuticals (Subject)
Tarriff Scott (Filed by)
| Form SC 13G/A | |
03/18/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-K | |
03/08/2024
3:49 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:40 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:35 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
7:23 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Crypto Is Set to Explode in December (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
02/29/2024
3:44 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
7:09 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
2:53 PM | Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/13/2024
7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
12:38 PM | BRANDES INVESTMENT PARTNERS, LP (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
8:15 AM | Eagle Pharmaceuticals (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
02/06/2024
4:09 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
1:04 PM | Eagle Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
5:56 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
4:00 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
4:01 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
6:00 PM | Eagle Pharmaceuticals (Issuer)
Graves Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:15 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K/A | |
